Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Towards an HIV cure: a global scientific strategy

International AIDS Society Scientific Working Group on HIV Cure, Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun TW, Churchill M, Di Mascio M, Katlama C, Lafeuillade A, Landay A, Lederman M, Lewin SR, Maldarelli F, Margolis D, Marko

(2012), Nat Rev Immunol, 12(8), 607-14

HIV infection and TLR signalling in the liver

Crane M, Visvanathan K, Lewin SR

(2012), Gastroenterol Res Pract, 2012, 473925

HIV-associated sensory neuropathy: still a problem in the post-stavudine era?

Cherry CL, Kamerman PR, Bennett DLH, Rice ASC

(2012), Future Virol, 7(9), 849-54

Measuring the accuracy of self-reported height and weight in a community-based sample of young people

Bowring AL, Peeters A, Freak-Poli R, Lim MS, Gouillou M, Hellard M

(2012), BMC Med Res Methodol, 12, 175

Plasma levels of JC virus are sensitive and specific for detecting and predicting progressive multifocal leukoencephalopathy in HIV patients

Bayliss J, CL Cherry, McLean CA

(2012), Future Virol, 7(8), 833-9

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand

Avihingsanon A, Matthews GV, Lewin SR, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Dore GJ, Ruxrungtham K

(2012), AIDS Res Ther, 9(1), 6

Circulating heat shock protein 60 levels are elevated in HIV patients and are reduced by anti-retroviral therapy

Anraku I, Rajasuriar R, Dobbin C, Brown R, Lewin SR, Suhrbier A

(2012), PLoS One, 7(9), e45291

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection

Alavi M, Grebely J, Matthews GV, Petoumenos K, Yeung B, Day C, Lloyd AR, Van Beek I, Kaldor JM, Hellard M, Dore GJ, Haber PS; ATAHC Study Group

(2012), J Gastroenterol Hepatol, 27(5), 957-65

Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients

Tran L, Kompa AR, Wang BH, Krum H

(2012), Cardiovasc Ther, 30(5), 295-300

Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies

Hering D, Walton A, Krum H, Lambert GW, Esler MD, Schlaich MP

(2012), Int J Cardiol, 159(2), e35-6

Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific)

Atherton JJ, Hayward CS, Wan Ahmad WA, Kwok B, Jorge J, Hernandez AF, Liang L, Kociol RD, Krum H; ADHERE International–Asia Pacific Scientific Advisory Committee

(2012), J Card Fail, 18(1), 82-8

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials

Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, Forbes A, Krum H

(2012), Eur J Heart Fail, 14(1), 91-105

Clinical trials update Esc congress 2011

Rosenson R, Horowitz J, Kaski JC, Krum H, Remme W

(2012), Cardiovasc Drugs Ther, 26(1), 77-84

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

McMurray JJ, Abraham WT, Dickstein K, Køber L, Massie BM, Krum H

(2012), Eur J Heart Fail, 14(4), 341-3

Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs

Krum H, Swergold G, Gammaitoni A, Peloso PM, Smugar SS, Curtis SP, Brater DC, Wang H, Kaur A, Laine L, Weir MR, Cannon CP

(2012), Cardiovasc Ther, 30(6), 342-50

Current modalities for invasive and non-invasive monitoring of volume status in heart failure

von Lueder TG, Krum H

(2012), Heart, 98(13), 967-73

Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate

Liu S, Wang BH, Kompa AR, Lekawanvijit S, Krum H

(2012), Int J Cardiol, 158(3), 457-8

FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy

Zhang Y, Edgley AJ, Cox AJ, Powell AK, Wang B, Kompa AR, Stapleton DI, Zammit SC, Williams SJ, Krum H, Gilbert RE, Kelly DJ

(2012), Eur J Heart Fail, 14(5), 549-62

Eplerenone for the treatment of cardiovascular disorders

Watanabe M, Krum H

(2012), Expert Rev Cardiovasc Ther, 10(7), 831-8

Peptidomic profiles of post myocardial infarction rats affinity depleted plasma using matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) mass spectrometry

Wang BH, Reisman S, Bailey M, Kompa A, Ayhan M, Krum H, Rice G

(2012), Clin Transl Med, 1(1), 11